CureVac N.V. (FRA:5CV)
4.566
-0.034 (-0.74%)
Jun 27, 2025, 8:02 PM CET
CureVac Employees
As of December 31, 2024, CureVac had 983 total employees, including 825 full-time and 158 part-time employees. The number of employees decreased by 189 or -16.13% compared to the previous year.
Employees
983
Change (1Y)
-189
Growth (1Y)
-16.13%
Revenue / Employee
€579,314
Profits / Employee
€199,840
Market Cap
1.03B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 91,864 |
Fresenius SE & Co. KGaA | 176,486 |
Sartorius Aktiengesellschaft | 13,528 |
Fresenius Medical Care AG | 111,513 |
Carl Zeiss Meditec AG | 5,730 |
Fielmann Group AG | 24,363 |
CureVac News
- 8 days ago - $HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of CureVac N.V. (NASDAQ: CVAC) - GlobeNewsWire
- 15 days ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, KNW, SOAR, HLGN on Behalf of Shareholders - GlobeNewsWire
- 16 days ago - This Sherwin-Williams Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday - Benzinga
- 16 days ago - BioNTech's Acquisition Of CureVac Brings Complementary Method To Target Cancer - Seeking Alpha
- 16 days ago - Stocks making the biggest midday moves: Oracle, Boeing, CureVac, Datadog and more - CNBC
- 16 days ago - Top Stock Movers Now: Oracle, Boeing, CureVac, and More - Investopedia
- 16 days ago - BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal - Benzinga
- 16 days ago - BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal - Benzinga